Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_assertion type Assertion NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_head.
- NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_assertion description "[As a main observation, carriers of the A allele of the CENPF SNP rs438034 had a worse BC-specific survival compared to the wild type genotype GG carriers (hazard ratio (HR) 2.65, 95% confidence interval (CI) 1.19-5.90), although they were less likely to have regional lymph node metastases (odds ratio (OR) 0.71, 95% CI 0.51-1.01) and tumours of stage II-IV (OR 0.73, 95% CI 0.54-0.99).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_provenance.
- NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_assertion evidence source_evidence_literature NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_provenance.
- NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_assertion SIO_000772 19008095 NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_provenance.
- NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_assertion wasDerivedFrom gad-20130706 NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_provenance.
- NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_assertion wasGeneratedBy ECO_0000203 NP78034.RADsJcNZAHE8coVqBveUwe-BC1lyCY41S9uX47dVVZIFk130_provenance.